The effect of low-molecular-weight heparin in cancer patients: the mirror image of survival?

Blood. 2014 Jul 3;124(1):155-6. doi: 10.1182/blood-2014-03-561761.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Anticoagulants / therapeutic use
  • Heparin, Low-Molecular-Weight / therapeutic use*
  • Humans
  • Nadroparin / therapeutic use*
  • Neoplasms / drug therapy*
  • Neoplasms / mortality*

Substances

  • Anticoagulants
  • Heparin, Low-Molecular-Weight
  • Nadroparin